Favourites   Have ideas?  Sign in / Register



Disease: Leukemia segment

GLYC GlycoMimetics, Inc. - Common Stock up -8% 8 + Biotechnology, Medicine, Disease: Leukemia

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.